Form 8-K · Current report
CDW Corporation 8-K, filed Nov 4, 2026
- Filed
- CIK
- 0001402057
- Accession no.
- 0001402057-26-000113
Summary
CDW reported third-quarter 2026 net sales of $6.76 billion, up 17.7% from a year earlier, and net income of $310 million, or $2.46 per diluted share, while declaring a quarterly cash dividend of $0.680 per common share; CEO Christine A. Leahy attributed the growth to broad-based demand across customer segments and enterprise AI adoption.
Key points
- Net sales rose 17.7% to $6,755 million on growth in data storage and servers, notebooks/mobile devices, and software, with non-GAAP net income per diluted share up 20.4% to $3.26.
- Gross profit margin declined to 20.5% from 21.9%, which the company attributed to mix into and lower margin in certain product categories.
- The board declared a quarterly cash dividend of $0.680 per common share, payable December 10, 2026 to stockholders of record as of November 25, 2026.
- Commercial segment net sales rose 20.8%, including a 73.2% increase to financial services customers, while government rose 9.9% and education 7.5%.
Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.
Items reported
- 2.02Results of Operations and Financial Condition
- 8.01Other Events
- 9.01Financial Statements and Exhibits
From the filing
Item 2.02. Results of Operations and Financial Condition. CDW Corporation (the “Company”) is furnishing under cover of this Current Report on Form 8-K a copy of its press release dated November 4, 2026 announcing its third quarter 2026 financial results. The press release is attached to this report as Exhibit 99.1 and incorporated herein by reference. The Company is furnishing this information in connection with its previously announced webcast conference call to be held on November 4, 2026 at 8:30 a.m. ET / 7:30 a.m. CT to discuss these results. …
An excerpt of the text as filed with the SEC, cut for length.
Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.